Log In
person
Takara Bio Inc
summarize
4 total product lines
calendar_month
Revenue as of 03/31/2021
| Reporting Segmentarrow_drop_up | Product Line | Amount (JPY) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (JPY) | Percentage |
| Drug Development |
Reagents, Chemicals and Proteins for Drug Manufacturers
These companies manufacture reagents, chemicals, and proteins that are used primarily used by drug manufacturers (pharma and biotech) and sell directly to their customers.
|
35.19B | 76.36% |
| Drug Development |
Pharmaceutical Contract Developer and Manufacturing Organizations (CDMOs)
These companies, commonly known as CDMOs, provide specialized services for drug manufacturers, such as drug discovery, research, development, and manufacturing.
|
8.9B | 19.31% |
| Drug Development |
Diagnostic Equipment for Medical Diagnostic Facilities (outsourced); sold through distributor
These companies outsource the manufacturing of medical diagnostic equipment for medical diagnostic facilities, such as chromatography test tubes, and sell them through wholesalers or distributors.
|
1.73B | 3.75% |
| Drug Development |
Pre-Revenue Gene Editing Pharmaceuticals
These companies research and develop pharmaceuticals related to gene editing, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
0.27B | 0.58% |
| keyboard_arrow_down |
Drug Development
Reagents, Chemicals and Proteins for Drug Manufacturers
|
35.19B | 76.36% |
| keyboard_arrow_right |
These companies manufacture reagents, chemicals, and proteins that are used primarily used by drug manufacturers (pharma and biotech) and sell directly to their customers.
|
||
| keyboard_arrow_down |
Drug Development
Pharmaceutical Contract Developer and Manufacturing Organizations (CDMOs)
|
8.9B | 19.31% |
| keyboard_arrow_right |
These companies, commonly known as CDMOs, provide specialized services for drug manufacturers, such as drug discovery, research, development, and manufacturing.
|
||
| keyboard_arrow_down |
Drug Development
Diagnostic Equipment for Medical Diagnostic Facilities (outsourced); sold through distributor
|
1.73B | 3.75% |
| keyboard_arrow_right |
These companies outsource the manufacturing of medical diagnostic equipment for medical diagnostic facilities, such as chromatography test tubes, and sell them through wholesalers or distributors.
|
||
| keyboard_arrow_down |
Drug Development
Pre-Revenue Gene Editing Pharmaceuticals
|
0.27B | 0.58% |
| keyboard_arrow_right |
These companies research and develop pharmaceuticals related to gene editing, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||